Information about Saint-Gilles Pharma
My details
*
*
*

Saint-Gilles Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0712.909.319

VAT liability
Yes
Established
07-11-2018
Last balance sheet year
2025
Company size
Small 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Saint-Gilles Pharma

2025 2024 2023 2022
Profit/Loss 10,615 -42% 18,303 479,06% -4,828 -168,14% 7,086
Equity 252,269 4,39% 241,654 8,19% 223,352 -2,12% 228,180
Gross margin 77,032 -10,16% 85,745 41,07% 60,782 -49,59% 120,585
Employees 0.9

Publications from Saint-Gilles Pharma

Date Publication
02-01-2024 Modification Legal Form - Resignations, Appointments (FR)
09-11-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Saint-Gilles Pharma?
The VAT number of Saint-Gilles Pharma is BE 0712.909.319.
Wat is the PEPPOL ID of Saint-Gilles Pharma?
The PEPPOL ID of Saint-Gilles Pharma is 0208:0712909319. Log in or start a free trial to see the full overview.
When was Saint-Gilles Pharma founded?
Saint-Gilles Pharma was founded on 07-11-2018.
What is the address of Saint-Gilles Pharma?
The current registered office of Saint-Gilles Pharma is located at Rue Saint-Gilles 278, 4000 Liège.
When was the last time Saint-Gilles Pharma filed their annual financial statements?
The most recent financial statements of Saint-Gilles Pharma were filed on 09-07-2026.
How many employees does Saint-Gilles Pharma have?
There are currently no employees working at Saint-Gilles Pharma or no workforce information is available.
What is the annual turnover of Saint-Gilles Pharma?
At the time of its most recent financial statements, Saint-Gilles Pharma did not publish any turnover figures. Saint-Gilles Pharma reported a gross margin of €77,032.49.